Hydrogen sulfide augments survival signals in warm ischemia and reperfusion of the mouse liver

[1]  P. Clavien,et al.  Hypothermic oxygenated perfusion (HOPE) protects from biliary injury in a rodent model of DCD liver transplantation. , 2013, Journal of hepatology.

[2]  P. Haouzi,et al.  H2S concentrations in the arterial blood during H2S administration in relation to its toxicity and effects on breathing. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[3]  H. Zhang,et al.  Hydrogen Sulfide Preconditioning Protects Rat Liver against Ischemia/Reperfusion Injury by Activating Akt-GSK-3β Signaling and Inhibiting Mitochondrial Permeability Transition , 2013, PloS one.

[4]  M. Nicholson,et al.  Effects of hydrogen sulphide in an experimental model of renal ischaemia–reperfusion injury , 2012, The British journal of surgery.

[5]  M. V. van Dijk,et al.  Beneficial effects of gaseous hydrogen sulfide in hepatic ischemia/reperfusion injury , 2012, Transplant international : official journal of the European Society for Organ Transplantation.

[6]  Kechen Ban,et al.  Protective Role of p70S6K in Intestinal Ischemia/Reperfusion Injury in Mice , 2012, PloS one.

[7]  Xueying Sun,et al.  The role of AKT1 and autophagy in the protective effect of hydrogen sulphide against hepatic ischemia/reperfusion injury in mice , 2012, Autophagy.

[8]  R. Banerjee,et al.  High turnover rates for hydrogen sulfide allow for rapid regulation of its tissue concentrations. , 2012, Antioxidants & redox signaling.

[9]  Diethard Monbaliu,et al.  Liver transplantation using Donation after Cardiac Death donors. , 2012, Journal of hepatology.

[10]  F. Gao,et al.  HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: regulation of TLR4 innate responses through PI3K/PTEN signaling. , 2012, Journal of hepatology.

[11]  R. Bhogal,et al.  Activation of CD40 with Platelet Derived CD154 Promotes Reactive Oxygen Species Dependent Death of Human Hepatocytes during Hypoxia and Reoxygenation , 2012, PloS one.

[12]  P. Koh.  Melatonin prevents hepatic injury‐induced decrease in Akt downstream targets phosphorylations , 2011, Journal of pineal research.

[13]  D. Lefer,et al.  Cytoprotective actions of hydrogen sulfide in ischaemia–reperfusion injury , 2011, Experimental physiology.

[14]  Joaquín V. Rodríguez,et al.  Delivery of the bioactive gas hydrogen sulfide during cold preservation of rat liver: effects on hepatic function in an ex vivo model. , 2011, Artificial organs.

[15]  F. Gao,et al.  Survivin: a novel player in insulin cardioprotection against myocardial ischemia/reperfusion injury. , 2011, Journal of molecular and cellular cardiology.

[16]  Y. Zhong,et al.  H2S Protects Hippocampal Neurons from Anoxia–Reoxygenation Through cAMP-Mediated PI3K/Akt/p70S6K Cell-Survival Signaling Pathways , 2011, Journal of Molecular Neuroscience.

[17]  Rainer Blasczyk,et al.  Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. , 2010, Biochemical pharmacology.

[18]  P. Henderson,et al.  Hydrogen sulfide attenuates intestinal ischemia‐reperfusion injury when delivered in the post‐ischemic period , 2010, Journal of gastroenterology and hepatology.

[19]  A. Seifalian,et al.  Liver ischemia/reperfusion injury: Processes in inflammatory networks—A review , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[20]  H. Masutani,et al.  Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2. , 2010, Pharmacology & therapeutics.

[21]  Weihui Zhang,et al.  Carbon monoxide-Releasing Molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats , 2010, BMC gastroenterology.

[22]  Y. Goto,et al.  Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. , 2010, Antioxidants & redox signaling.

[23]  F. Gao,et al.  CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury , 2009, Hepatology.

[24]  Xueying Sun,et al.  Role of hydrogen sulfide in hepatic ischemia‐reperfusion–induced injury in rats , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[25]  Brigitte Vollmar,et al.  The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. , 2009, Physiological reviews.

[26]  S. Jha,et al.  Hydrogen Sulfide Mediates Cardioprotection Through Nrf2 Signaling , 2009, Circulation research.

[27]  Mark R. Duranski,et al.  Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling. , 2008, American journal of physiology. Heart and circulatory physiology.

[28]  B. Geng,et al.  Hydrogen sulfide protects rat lung from ischemia-reperfusion injury. , 2008, Life sciences.

[29]  K. Wood,et al.  Interleukin-23 and TH17 cells in transplantation immunity: does 23+17 equal rejection? , 2007, Transplantation.

[30]  C. Szabó.  Hydrogen sulphide and its therapeutic potential , 2007, Nature Reviews Drug Discovery.

[31]  Csaba Szabo,et al.  Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function , 2007, Proceedings of the National Academy of Sciences.

[32]  P. Moore,et al.  Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways , 2007, Pflügers Archiv - European Journal of Physiology.

[33]  J. Bełtowski,et al.  Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists. , 2007, Pharmacological reports : PR.

[34]  R. Schuster,et al.  Potential role for IL-23 in hepatic ischemia/reperfusion injury , 2006, Inflammation Research.

[35]  S. Todo,et al.  Lipid peroxidation during ischemia depends on ischemia time in warm ischemia and reperfusion of rat liver. , 2005, Free radical biology & medicine.

[36]  G. Baxter,et al.  Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia–reperfusion injury , 2005, Basic Research in Cardiology.

[37]  K. Olthoff,et al.  Severe Preservation Injury Induces Il‐6/STAT3 Activation with Lack of Cell Cycle Progression After Partial Liver Graft Transplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[38]  R. Taub.  Liver regeneration: from myth to mechanism , 2004, Nature Reviews Molecular Cell Biology.

[39]  M. Mocanu,et al.  Postconditioning: A Form of “Modified Reperfusion” Protects the Myocardium by Activating the Phosphatidylinositol 3-Kinase–Akt Pathway , 2004, Circulation research.

[40]  F. Bach,et al.  Heme oxygenase‐1‐derived carbon monoxide protects hearts from transplant‐associated ischemia reperfusion injury , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  D. Yellon,et al.  Second window of protection following myocardial preconditioning: an essential role for PI3 kinase and p70S6 kinase. , 2003, Journal of molecular and cellular cardiology.

[42]  Norihiko Kondo,et al.  Thioredoxin-dependent redox regulation of the antioxidant responsive element (ARE) in electrophile response , 2003, Oncogene.

[43]  T. Sugawara,et al.  Evidence of Phosphorylation of Akt and Neuronal Survival after Transient Focal Cerebral Ischemia in Mice , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[44]  E. Hiyama,et al.  Kupffer Cell Function in Ischemic and Nonischemic Livers After Hepatic Partial Ischemia/Reperfusion , 2001, Surgery Today.

[45]  横田 良一.  A novel hydroxyl radical scavenger, nicaraven, protects the liver from warm ischemia and reperfusion injury , 2000 .

[46]  P. Clavien,et al.  A new and simple technique of total hepatic ischemia in the mouse. , 1998, Transplantation.

[47]  L. Oberley,et al.  Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-κB activation , 1998, Nature Medicine.

[48]  J. Engelhardt,et al.  Redox gene therapy of liver ischemia/reperfusion injury reduces AP-1 and NF-KB activation , 1998 .

[49]  太田徹哉.  Endothelin-1 Levels in Portal Venous Blood in Relation to Hepatic Tissue Microcirculation Disturbance and Hepatic Cell Injury After Ischemia/Reperfusion(肝阻血再灌流後の,門脈血中エンドセリンー1濃度と肝微小循環障害及び肝細胞障害との関係) , 1997 .

[50]  Shohachi Suzuki,et al.  THE BENEFICIAL EFFECT OF A PROSTAGLANDIN 12 ANALOG ON ISCHEMIC RAT LIVER , 1991, Transplantation.